How Big Will the SpaceX IPO Be?
Operated up to now as a private business, SpaceX will…
Buy
53
XHS Quote, Financials, Valuation and Earnings
Last price:
$105.70
Seasonality move
:
0.45%
Day range:
$105.42 - $106.56
52-week range:
$87.64 - $112.09
Dividend yield:
0.26%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
2.8K
Avg. volume:
12.1K
1-year change:
3.53%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
XHS
State Street SPDR S&P Health Care Services ETF
|
-- | -- | -- | -- | -- |
|
PBE
Invesco Biotechnology & Genome ETF
|
-- | -- | -- | -- | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
-- | -- | -- | -- | -- |
|
XBI
State Street SPDR S&P Biotech ETF
|
-- | -- | -- | -- | -- |
|
XHE
State Street SPDR S&P Health Care Equipment ETF
|
-- | -- | -- | -- | -- |
|
XPH
State Street SPDR S&P Pharmaceuticals ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
XHS
State Street SPDR S&P Health Care Services ETF
|
$111.46 | -- | -- | -- | $0.12 | 0.26% | -- |
|
PBE
Invesco Biotechnology & Genome ETF
|
$82.36 | -- | -- | -- | $0.42 | 0.99% | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
$104.62 | -- | -- | -- | $0.25 | 0.98% | -- |
|
XBI
State Street SPDR S&P Biotech ETF
|
$127.86 | -- | -- | -- | $0.41 | 0.35% | -- |
|
XHE
State Street SPDR S&P Health Care Equipment ETF
|
$88.28 | -- | -- | -- | $0.02 | 0.08% | -- |
|
XPH
State Street SPDR S&P Pharmaceuticals ETF
|
$56.36 | -- | -- | -- | $0.11 | 0.83% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
XHS
State Street SPDR S&P Health Care Services ETF
|
-- | 0.719 | -- | -- |
|
PBE
Invesco Biotechnology & Genome ETF
|
-- | 0.675 | -- | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
-- | 0.051 | -- | -- |
|
XBI
State Street SPDR S&P Biotech ETF
|
-- | 0.938 | -- | -- |
|
XHE
State Street SPDR S&P Health Care Equipment ETF
|
-- | 0.957 | -- | -- |
|
XPH
State Street SPDR S&P Pharmaceuticals ETF
|
-- | 0.254 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
XHS
State Street SPDR S&P Health Care Services ETF
|
-- | -- | -- | -- | -- | -- |
|
PBE
Invesco Biotechnology & Genome ETF
|
-- | -- | -- | -- | -- | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
-- | -- | -- | -- | -- | -- |
|
XBI
State Street SPDR S&P Biotech ETF
|
-- | -- | -- | -- | -- | -- |
|
XHE
State Street SPDR S&P Health Care Equipment ETF
|
-- | -- | -- | -- | -- | -- |
|
XPH
State Street SPDR S&P Pharmaceuticals ETF
|
-- | -- | -- | -- | -- | -- |
State Street SPDR S&P Health Care Services ETF vs. Competitors
-
Which has Higher Returns XHS or PBE?
Invesco Biotechnology & Genome ETF has a net margin of -- compared to State Street SPDR S&P Health Care Services ETF's net margin of --. State Street SPDR S&P Health Care Services ETF's return on equity of -- beat Invesco Biotechnology & Genome ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XHSState Street SPDR S&P Health Care Services ETF-- -- -- PBEInvesco Biotechnology & Genome ETF-- -- -- -
What do Analysts Say About XHS or PBE?
State Street SPDR S&P Health Care Services ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Biotechnology & Genome ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that State Street SPDR S&P Health Care Services ETF has higher upside potential than Invesco Biotechnology & Genome ETF, analysts believe State Street SPDR S&P Health Care Services ETF is more attractive than Invesco Biotechnology & Genome ETF.
Company Buy Ratings Hold Ratings Sell Ratings XHSState Street SPDR S&P Health Care Services ETF0 0 0 PBEInvesco Biotechnology & Genome ETF0 0 0 -
Is XHS or PBE More Risky?
State Street SPDR S&P Health Care Services ETF has a beta of 1.014, which suggesting that the stock is 1.381% more volatile than S&P 500. In comparison Invesco Biotechnology & Genome ETF has a beta of 0.802, suggesting its less volatile than the S&P 500 by 19.831%.
-
Which is a Better Dividend Stock XHS or PBE?
State Street SPDR S&P Health Care Services ETF has a quarterly dividend of $0.12 per share corresponding to a yield of 0.26%. Invesco Biotechnology & Genome ETF offers a yield of 0.99% to investors and pays a quarterly dividend of $0.42 per share. State Street SPDR S&P Health Care Services ETF pays -- of its earnings as a dividend. Invesco Biotechnology & Genome ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XHS or PBE?
State Street SPDR S&P Health Care Services ETF quarterly revenues are --, which are smaller than Invesco Biotechnology & Genome ETF quarterly revenues of --. State Street SPDR S&P Health Care Services ETF's net income of -- is lower than Invesco Biotechnology & Genome ETF's net income of --. Notably, State Street SPDR S&P Health Care Services ETF's price-to-earnings ratio is -- while Invesco Biotechnology & Genome ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for State Street SPDR S&P Health Care Services ETF is -- versus -- for Invesco Biotechnology & Genome ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XHSState Street SPDR S&P Health Care Services ETF-- -- -- -- PBEInvesco Biotechnology & Genome ETF-- -- -- --
-
Which has Higher Returns XHS or PJP?
Invesco Pharmaceuticals ETF has a net margin of -- compared to State Street SPDR S&P Health Care Services ETF's net margin of --. State Street SPDR S&P Health Care Services ETF's return on equity of -- beat Invesco Pharmaceuticals ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XHSState Street SPDR S&P Health Care Services ETF-- -- -- PJPInvesco Pharmaceuticals ETF-- -- -- -
What do Analysts Say About XHS or PJP?
State Street SPDR S&P Health Care Services ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Pharmaceuticals ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that State Street SPDR S&P Health Care Services ETF has higher upside potential than Invesco Pharmaceuticals ETF, analysts believe State Street SPDR S&P Health Care Services ETF is more attractive than Invesco Pharmaceuticals ETF.
Company Buy Ratings Hold Ratings Sell Ratings XHSState Street SPDR S&P Health Care Services ETF0 0 0 PJPInvesco Pharmaceuticals ETF0 0 0 -
Is XHS or PJP More Risky?
State Street SPDR S&P Health Care Services ETF has a beta of 1.014, which suggesting that the stock is 1.381% more volatile than S&P 500. In comparison Invesco Pharmaceuticals ETF has a beta of 0.493, suggesting its less volatile than the S&P 500 by 50.744%.
-
Which is a Better Dividend Stock XHS or PJP?
State Street SPDR S&P Health Care Services ETF has a quarterly dividend of $0.12 per share corresponding to a yield of 0.26%. Invesco Pharmaceuticals ETF offers a yield of 0.98% to investors and pays a quarterly dividend of $0.25 per share. State Street SPDR S&P Health Care Services ETF pays -- of its earnings as a dividend. Invesco Pharmaceuticals ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XHS or PJP?
State Street SPDR S&P Health Care Services ETF quarterly revenues are --, which are smaller than Invesco Pharmaceuticals ETF quarterly revenues of --. State Street SPDR S&P Health Care Services ETF's net income of -- is lower than Invesco Pharmaceuticals ETF's net income of --. Notably, State Street SPDR S&P Health Care Services ETF's price-to-earnings ratio is -- while Invesco Pharmaceuticals ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for State Street SPDR S&P Health Care Services ETF is -- versus -- for Invesco Pharmaceuticals ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XHSState Street SPDR S&P Health Care Services ETF-- -- -- -- PJPInvesco Pharmaceuticals ETF-- -- -- --
-
Which has Higher Returns XHS or XBI?
State Street SPDR S&P Biotech ETF has a net margin of -- compared to State Street SPDR S&P Health Care Services ETF's net margin of --. State Street SPDR S&P Health Care Services ETF's return on equity of -- beat State Street SPDR S&P Biotech ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XHSState Street SPDR S&P Health Care Services ETF-- -- -- XBIState Street SPDR S&P Biotech ETF-- -- -- -
What do Analysts Say About XHS or XBI?
State Street SPDR S&P Health Care Services ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand State Street SPDR S&P Biotech ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that State Street SPDR S&P Health Care Services ETF has higher upside potential than State Street SPDR S&P Biotech ETF, analysts believe State Street SPDR S&P Health Care Services ETF is more attractive than State Street SPDR S&P Biotech ETF.
Company Buy Ratings Hold Ratings Sell Ratings XHSState Street SPDR S&P Health Care Services ETF0 0 0 XBIState Street SPDR S&P Biotech ETF0 0 0 -
Is XHS or XBI More Risky?
State Street SPDR S&P Health Care Services ETF has a beta of 1.014, which suggesting that the stock is 1.381% more volatile than S&P 500. In comparison State Street SPDR S&P Biotech ETF has a beta of 0.922, suggesting its less volatile than the S&P 500 by 7.765%.
-
Which is a Better Dividend Stock XHS or XBI?
State Street SPDR S&P Health Care Services ETF has a quarterly dividend of $0.12 per share corresponding to a yield of 0.26%. State Street SPDR S&P Biotech ETF offers a yield of 0.35% to investors and pays a quarterly dividend of $0.41 per share. State Street SPDR S&P Health Care Services ETF pays -- of its earnings as a dividend. State Street SPDR S&P Biotech ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XHS or XBI?
State Street SPDR S&P Health Care Services ETF quarterly revenues are --, which are smaller than State Street SPDR S&P Biotech ETF quarterly revenues of --. State Street SPDR S&P Health Care Services ETF's net income of -- is lower than State Street SPDR S&P Biotech ETF's net income of --. Notably, State Street SPDR S&P Health Care Services ETF's price-to-earnings ratio is -- while State Street SPDR S&P Biotech ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for State Street SPDR S&P Health Care Services ETF is -- versus -- for State Street SPDR S&P Biotech ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XHSState Street SPDR S&P Health Care Services ETF-- -- -- -- XBIState Street SPDR S&P Biotech ETF-- -- -- --
-
Which has Higher Returns XHS or XHE?
State Street SPDR S&P Health Care Equipment ETF has a net margin of -- compared to State Street SPDR S&P Health Care Services ETF's net margin of --. State Street SPDR S&P Health Care Services ETF's return on equity of -- beat State Street SPDR S&P Health Care Equipment ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XHSState Street SPDR S&P Health Care Services ETF-- -- -- XHEState Street SPDR S&P Health Care Equipment ETF-- -- -- -
What do Analysts Say About XHS or XHE?
State Street SPDR S&P Health Care Services ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand State Street SPDR S&P Health Care Equipment ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that State Street SPDR S&P Health Care Services ETF has higher upside potential than State Street SPDR S&P Health Care Equipment ETF, analysts believe State Street SPDR S&P Health Care Services ETF is more attractive than State Street SPDR S&P Health Care Equipment ETF.
Company Buy Ratings Hold Ratings Sell Ratings XHSState Street SPDR S&P Health Care Services ETF0 0 0 XHEState Street SPDR S&P Health Care Equipment ETF0 0 0 -
Is XHS or XHE More Risky?
State Street SPDR S&P Health Care Services ETF has a beta of 1.014, which suggesting that the stock is 1.381% more volatile than S&P 500. In comparison State Street SPDR S&P Health Care Equipment ETF has a beta of 1.113, suggesting its more volatile than the S&P 500 by 11.281%.
-
Which is a Better Dividend Stock XHS or XHE?
State Street SPDR S&P Health Care Services ETF has a quarterly dividend of $0.12 per share corresponding to a yield of 0.26%. State Street SPDR S&P Health Care Equipment ETF offers a yield of 0.08% to investors and pays a quarterly dividend of $0.02 per share. State Street SPDR S&P Health Care Services ETF pays -- of its earnings as a dividend. State Street SPDR S&P Health Care Equipment ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XHS or XHE?
State Street SPDR S&P Health Care Services ETF quarterly revenues are --, which are smaller than State Street SPDR S&P Health Care Equipment ETF quarterly revenues of --. State Street SPDR S&P Health Care Services ETF's net income of -- is lower than State Street SPDR S&P Health Care Equipment ETF's net income of --. Notably, State Street SPDR S&P Health Care Services ETF's price-to-earnings ratio is -- while State Street SPDR S&P Health Care Equipment ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for State Street SPDR S&P Health Care Services ETF is -- versus -- for State Street SPDR S&P Health Care Equipment ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XHSState Street SPDR S&P Health Care Services ETF-- -- -- -- XHEState Street SPDR S&P Health Care Equipment ETF-- -- -- --
-
Which has Higher Returns XHS or XPH?
State Street SPDR S&P Pharmaceuticals ETF has a net margin of -- compared to State Street SPDR S&P Health Care Services ETF's net margin of --. State Street SPDR S&P Health Care Services ETF's return on equity of -- beat State Street SPDR S&P Pharmaceuticals ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XHSState Street SPDR S&P Health Care Services ETF-- -- -- XPHState Street SPDR S&P Pharmaceuticals ETF-- -- -- -
What do Analysts Say About XHS or XPH?
State Street SPDR S&P Health Care Services ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand State Street SPDR S&P Pharmaceuticals ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that State Street SPDR S&P Health Care Services ETF has higher upside potential than State Street SPDR S&P Pharmaceuticals ETF, analysts believe State Street SPDR S&P Health Care Services ETF is more attractive than State Street SPDR S&P Pharmaceuticals ETF.
Company Buy Ratings Hold Ratings Sell Ratings XHSState Street SPDR S&P Health Care Services ETF0 0 0 XPHState Street SPDR S&P Pharmaceuticals ETF0 0 0 -
Is XHS or XPH More Risky?
State Street SPDR S&P Health Care Services ETF has a beta of 1.014, which suggesting that the stock is 1.381% more volatile than S&P 500. In comparison State Street SPDR S&P Pharmaceuticals ETF has a beta of 0.637, suggesting its less volatile than the S&P 500 by 36.325%.
-
Which is a Better Dividend Stock XHS or XPH?
State Street SPDR S&P Health Care Services ETF has a quarterly dividend of $0.12 per share corresponding to a yield of 0.26%. State Street SPDR S&P Pharmaceuticals ETF offers a yield of 0.83% to investors and pays a quarterly dividend of $0.11 per share. State Street SPDR S&P Health Care Services ETF pays -- of its earnings as a dividend. State Street SPDR S&P Pharmaceuticals ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XHS or XPH?
State Street SPDR S&P Health Care Services ETF quarterly revenues are --, which are smaller than State Street SPDR S&P Pharmaceuticals ETF quarterly revenues of --. State Street SPDR S&P Health Care Services ETF's net income of -- is lower than State Street SPDR S&P Pharmaceuticals ETF's net income of --. Notably, State Street SPDR S&P Health Care Services ETF's price-to-earnings ratio is -- while State Street SPDR S&P Pharmaceuticals ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for State Street SPDR S&P Health Care Services ETF is -- versus -- for State Street SPDR S&P Pharmaceuticals ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XHSState Street SPDR S&P Health Care Services ETF-- -- -- -- XPHState Street SPDR S&P Pharmaceuticals ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will ISRG Stock Be in 5 Years?
Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…
Is Kratos Stock a Good Investment?
UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.7T
P/E Ratio: 65x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 42x
Sell
48
Is GOOGL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 42x
Alerts
Buy
72
BNAI alert for Jan 29
Brand Engagement Network, Inc. [BNAI] is down 16.89% over the past day.
Buy
82
STX alert for Jan 29
Seagate Technology Holdings Plc [STX] is up 0.83% over the past day.
Buy
84
GDXU alert for Jan 29
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is down 12.19% over the past day.
